174 related articles for article (PubMed ID: 12946231)
21. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
22. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
23. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
Xie W; Wang X; Du W; Liu W; Qin X; Huang S
Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
[TBL] [Abstract][Full Text] [Related]
24. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
Zhang Y; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
[TBL] [Abstract][Full Text] [Related]
25. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
Merchant SH; Gonchoroff NJ; Hutchison RE
Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
[TBL] [Abstract][Full Text] [Related]
27. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
28. Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias.
Wells DA; Hall MC; Shulman HM; Loken MR
Leukemia; 1998 Dec; 12(12):2015-23. PubMed ID: 9844932
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia and related conditions.
Todd WM
Hematol Oncol Clin North Am; 2002 Apr; 16(2):301-19. PubMed ID: 12094474
[TBL] [Abstract][Full Text] [Related]
30. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.
van de Loosdrecht AA; Westers TM; Westra AH; Dräger AM; van der Velden VH; Ossenkoppele GJ
Blood; 2008 Feb; 111(3):1067-77. PubMed ID: 17971483
[TBL] [Abstract][Full Text] [Related]
31. Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.
Ok CY; Leventaki V; Wang SA; Dinardo C; Medeiros LJ; Konoplev S
Am J Clin Pathol; 2016 Feb; 145(2):271-6. PubMed ID: 26800764
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
Stetler-Stevenson M; Arthur DC; Jabbour N; Xie XY; Molldrem J; Barrett AJ; Venzon D; Rick ME
Blood; 2001 Aug; 98(4):979-87. PubMed ID: 11493442
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes.
De Smet D; Trullemans F; Jochmans K; Renmans W; Smet L; Heylen O; Bael AM; Schots R; Leus B; De Waele M
Am J Clin Pathol; 2012 Nov; 138(5):732-43. PubMed ID: 23086775
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
[TBL] [Abstract][Full Text] [Related]
35. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders.
Wood BL
J Biol Regul Homeost Agents; 2004; 18(2):141-5. PubMed ID: 15471218
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.
Stachurski D; Smith BR; Pozdnyakova O; Andersen M; Xiao Z; Raza A; Woda BA; Wang SA
Leuk Res; 2008 Feb; 32(2):215-24. PubMed ID: 17675229
[TBL] [Abstract][Full Text] [Related]
38. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
[TBL] [Abstract][Full Text] [Related]
39. GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML.
Hanumanthu VS; Pirruccello SJ
Am J Clin Pathol; 2013 Aug; 140(2):155-64. PubMed ID: 23897249
[TBL] [Abstract][Full Text] [Related]
40. Loss of blast heterogeneity in myelodysplastic syndrome and other chronic myeloid neoplasms.
Jevremovic D; Timm MM; Reichard KK; Morice WG; Hanson CA; Viswanatha DS; Howard MT; Nguyen PL
Am J Clin Pathol; 2014 Sep; 142(3):292-8. PubMed ID: 25125617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
